Mukka Proteins Peer Comparison

NSE: MUKKA | BSE: 544135

₹27.91

₹-0.95 (-3.29%)

As on 16-Oct-2026IST

Market cap

₹841 Cr

Revenue (TTM)

₹1,768 Cr

P/E Ratio

12.2

P/B Ratio

1.6

Div. Yield

0 %

Edit

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Market cap (₹ Cr)	841	29,512	14,417	14,093	8,172
Revenue (₹ Cr)	1,768	2,250	3,813	3,172	950
Net Profit (₹ Cr)	72.56	361.74	400.90	521.27	266.00
Net Margin (%)	4.04	15.77	10.30	15.92	27.44
RoE (%)	14.65	15.47	13.87	18.10	72.69
Price to Earnings	12.16	81.58	35.96	27.27	30.72
Price-To-Book	1.62	11.56	4.49	4.43	23.49

Income Statement (₹ Cr)

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Operating Revenue	1,449.45	2,192.49	3,510.50	2,950.94	878.40
Total Income	1,478.13	2,266.90	3,582.50	3,033.47	896.80
Total Expenditure	1,334.87	1,584.97	2,891.50	2,350.16	569.40
EBITDA	114.58	607.53	619.00	600.78	309.00
Depreciation	16.59	166.86	126.40	98.63	11.70
EBIT	97.99	440.67	492.60	502.15	297.30
Interest	53.60	40.88	19.30	24.13	2.00
Other Income	28.68	74.40	72.00	82.53	18.40
Exceptional Items	--	-8.00	-20.30	--	6.60
Profit before Tax	75.14	466.19	525.00	560.56	320.30
Provision for Tax	18.06	117.28	123.90	140.49	80.20
Profit after Tax	57.09	348.91	401.10	420.06	240.10

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Shareholder's Funds	499.09	2,483.69	3,138.70	3,023.16	384.00
Minority Interest	29.69	--	--	29.52	--
Non-Current Liabilities	43.05	321.65	318.60	268.17	229.90
Current Liabilities	1,048.93	904.59	1,086.20	527.09	128.40
Total Liabilities	1,621.13	3,709.93	4,620.30	3,855.82	750.80

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Non-Current Assets	331.92	2,228.49	1,925.10	1,125.20	248.00
Current Assets	1,288.83	1,481.44	2,618.40	2,722.74	494.30
Total Assets	1,621.13	3,709.93	4,620.30	3,855.82	750.80
Total Debt*	767.77	95.13	0.00	29.59	0.00
Net Current Assets	239.90	576.85	1,532.20	2,195.65	365.90
Contingent Liabilities	61.31	97.31	--	--	1.50

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Cash From Operating Activities	-111.27	509.13	650.80	458.13	174.80
Cash Flow from Investing Activities	-145.98	-395.41	-512.40	-248.27	7.60
Cash from Financing Activities	267.05	-123.68	-82.60	-70.93	-134.50
Net Cash Inflow / Outflow	9.81	-9.96	55.80	138.93	47.90

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
ROCE (%)	11.93	20.97	18.92	21.10	98.11
ROE (%)	12.15	15.16	14.14	15.31	73.20
ROA (%)	4.23	10.09	10.31	11.85	37.26
EBIT Margin (%)	9.88	31.10	19.68	23.16	37.27
Net Margin (%)	3.86	15.39	11.20	13.85	26.77
Cash Profit Margin (%)	4.98	23.50	15.03	17.07	27.35

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Revenue Growth (%)	44.02	29.38	23.64	12.51	21.24
EBIT Growth (%)	30.24	53.37	7.72	14.07	15.44
Net Profit Growth (%)	18.69	105.08	-1.38	9.79	32.65
EPS Growth (%)	12.06	101.82	-1.79	9.81	32.65
Book Value Growth (%)	13.25	16.76	19.89	22.41	41.18

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Price / Earnings	10.60	58.91	26.06	17.04	43.36
Price / Book Value	1.11	8.29	3.38	2.36	27.11
Dividend Yield (%)	0.00	0.00	0.52	0.57	1.66
EV/EBITDA	8.79	30.12	14.57	9.02	30.65
Market Cap (₹ Cr)	551.66	20,554.39	10,450.76	7,121.50	10,410.62

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Debt to Equity	1.54	0.04	0.00	0.01	0.00
Short term debt to equity ratio	1.44	0.03	--	0.01	--
Current Ratio	1.23	1.64	2.41	5.17	3.85
Quick Ratio	0.41	1.47	2.41	3.32	3.37
Interest Coverage	2.40	12.40	28.20	24.24	161.15

	Mukka Proteins	Sai Life Sciences	Indegene	Marksans Pharma	Sanofi Consumer Healthcare India
Debtors to sales (%)	12.55	17.04	27.97	21.84	3.37
Asset Turnover	1.10	0.63	0.90	0.86	1.43
Receivable days	47.06	60.56	90.10	71.16	8.58
Inventory Days	175.18	22.43	0.00	109.20	20.38
Payable days	59.68	194.31	--	91.82	118.89
Cash Conversion Cycle	162.56	-111.32	--	88.55	-89.93

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.